|
Research GrantsMEHMET BILGENRadiology. Detection of Live Fibers in Injured Spinal Cord, $61,244 from National Institute of Neurological Disorders and Stroke , November 2007 through February 2009. DEBORAH ANNE BOWLBY Pediatrics. Recombinant Human Growth Hormone and Recombinant Human Insulin-Like Growth Factor-1 Combination Therapy in Children with Short Stature Associated with IGF-1 Deficiency: A Three-year, Randomized, Multi-Center, Open-Label, Parallel-Group, Active Treatment Controlled, Dose Selection Trial, $56,640 from Tercica Inc., January through January 2012. MARIA G. BUSE Medicine. Factors that Modify Insulin Action -Bridge Funding, $50,000 from The Endocrine Society, February through January 2009. ANGIE M. CASON Neurosciences. Drugs of Abuse, Gender Differences, and Protection by Sweets, $46,826 from National Institute on Drug Abuse, February through January 2009. WILLIAM T. CREASMAN Obstetrics and Gynecology. A Non-Interventional, Longitudinal, Multi-Center Initiative Examining Outcomes Associated with the Use of the ChemoFx Assay in Solid Tumor Malignancies, $59,250 from Precision Therapeutics Inc., February through March 2013. PHILLIPPE CUNNINGHAM Psychiatry and Behavioral Sciences. Adapting MST to Improve Food Choices and Health Outcomes in Obese African American Youth, $7,892 from Wayne State University, July 2007 through June. VINCENT DAMMAI Pathology and Laboratory Medicine. Cellular Factors Promoting Renal Cell Carcinoma, $221,920 from National Cancer Institute, February through January 2009. MICHAEL DE ARELLANO ALYSSA ANN RHEINGOLD (Co-PI) Psychiatry and Behavioral Sciences. Establishing the Violence against Hispanic Women Network, $61,645 from SC Department of Public Safety, October 2007 through September. MAURIZIO DEL POETA Biochemistry and Molecular Biology. Sphingolipid-Mediated Fungal Pathogenesis, $193,809 from National Institute of Allergy and Infectious Diseases, February through January 2009. HARRY DRABKIN Medicine. A Double-Blind, Randomized, Placebo-Controlled, Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer, $85,731 from GlaxoSmithKline, November 2007 through February 2013. GARY GILKESON Medicine. Complement in the Pathogenesis of Autoimmune Arthritis, $52,567 from University of Colorado, September 2007 through August. ROBERT GOURDIE Cell Biology and Anatomy. Function of CX43-Interacting Proteins in Neural Crest Migration, $354,415 from National Heart, Lung and Blood Institute, January through December. YUSUF A. HANNUN Biochemistry and Molecular Biology. SCIEX 4000 QTRAP Mass Spectrometer, $385,401 from National Center for Research Resources, February through February 2009. Modeling and Analysis of Roles of Yeast Sphingolipids, $274,852 from National Institute of General Medical Sciences, February through January 2009. TAIN-YEN HSIA Surgery XUEJUN WEN (Co-PI) Cell Biology and Anatomy. Wireless Sensors for Intracardiac Monitoring in Congenital Heart Defects, $150,000 from March of Dimes, February through January 2010. JOHN IKONOMIDIS Surgery. Extracellular Mechanisms for Thoracic Aortic Aneurysms - Supplement, 462,297 from National Heart, Lung and Blood Institute, December 2007 through November. AYAD A. JAFFA Medicine. Lipoproteins, CTGF and Diabetic Vascular and Renal Disease, 4354,415 from National Heart, Lung and Blood Institutem February through January 2009. LANKUPALLE D. JAYANTHI Neurosciences. Norepinephrine Transport Regulation by Phosphorylation, $220,460 from National Institute of General Medical Sciences, February through January 2009. MUSH KHAN Pediatrics. Mushfiqiddin Khan VA IPA, $44,691 from VAMC IPA, February through December. ANDREW KRAFT Medicine. A Pivotal Trial to Determine the Efficacy and Safety of AP23573 When Administered as Maintenance Therapy to Patients with Metastatic Soft-Tissue or Bone Sarcomas, $118,500 from Ariad Pharmaceuticals Inc., January through February 2012. JAMES S. KRAUSE Rehabilitation Sciences MARK S. KINDY (Co-PI) Neurosciences. Center for Interdisciplinary Spinal Cord Injury Research, $172,107 from SC Spinal Cord Injury Fund, February through January 2009. SERGEY KRUPENKO Biochemistry and Molecular Biology. FDH: A Novel Determinant of Tumor Suppression, $196,854 from National Cancer Institute, February through January 2009. ANGELA LAROSA Pediatrics. A 10 Week, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride (Aricept) in the Treatment of the Cognitive Dysfunction Exhibited by Children with Down Syndrome, $65,200 from Pfizer Inc., January through January 2009. HAINAN LANG Pathology and Laboratory Medicine. Cell Survival and Cell Death in the Auditory Nerve, 470,883 from National Institute on Deafness and Other Communication Disorders, February through January 2009. STEPHEN M. LANIER Cell and Molecular Pharmacology. AGS1 and Signal Processing by G-Protein, $297,915 from National Institute of General Medical Sciences, February through January 2009. ANTONIETA LAVIN Neurosciences. Neuropsychiatric Phenomics, $45,666 from University of California, Los Angeles, September 2007 through June. Updated May 2, 2008 Catalyst Online is published weekly, updated as needed and improved from time to time by the MUSC Office of Public Relations for the faculty, employees and students of the Medical University of South Carolina. Catalyst Online editor, Kim Draughn, can be reached at 792-4107 or by email, catalyst@musc.edu. Editorial copy can be submitted to Catalyst Online and to The Catalyst in print by fax, 792-6723, or by email to catalyst@musc.edu. To place an ad in The Catalyst hardcopy, call Island Papers at 849-1778, ext 201. |
| Catalyst Menu |Campus News | Community Happenings | Grantland |Research Studies |Seminars and Events |Speakers Bureau | Applause | Archives |Charleston Links |Medical Links |MUSC | |